Literature DB >> 26890852

Localized peritoneal carcinomatosis mimicking an irreducible left inguinal hernia.

N C Buchs1, A L A Bloemendaal1, R J Guy1.   

Abstract

Perforated colonic cancers are not rare and leave patients at risk of developing peritoneal carcinomatosis. We present a 68-year-old male patient with a perforated transverse colonic tumour who underwent emergency extended right hemicolectomy. He made an uneventful postoperative recovery, and received adjuvant chemotherapy. Unfortunately, a routine positron emission tomography-computed tomography scan 16 months later demonstrated an fluorodeoxyglucose-avid nodule in the left scrotum associated with an irreducible left inguinal hernia that contained sigmoid colon. At laparotomy, the discovery of isolated peritoneal recurrence in the hernia sac was unexpected, given the absence of local recurrence in the region of the original transverse colon cancer perforation. The etiology therefore remains uncertain, but one may speculate that cell implantation occurred within the hernia sac at the initial emergency laparotomy.

Entities:  

Keywords:  Colorectal cancer; PET/CT; Perforation; Peritoneal carcinomatosis; Recurrence; Treatment

Mesh:

Year:  2016        PMID: 26890852      PMCID: PMC5226177          DOI: 10.1308/rcsann.2016.0092

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

1.  Incarcerated inguinal hernia from metastatic pleural mesothelioma: PET/CT imaging.

Authors:  Vien X Nguyen; Ba D Nguyen; Panol C Ram; Michael C Roarke
Journal:  Clin Nucl Med       Date:  2012-05       Impact factor: 7.794

2.  Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.

Authors:  Cécile Berthelot; Olivier Morel; Sylvie Girault; Véronique Verrièle; Anne-Lise Poirier; Julien Moroch; Yvan Boucher; Jean-Jacques Le Jeune; Gérard Lorimier
Journal:  Nucl Med Commun       Date:  2011-01       Impact factor: 1.690

3.  Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.

Authors:  J Segelman; F Granath; T Holm; M Machado; H Mahteme; A Martling
Journal:  Br J Surg       Date:  2012-01-27       Impact factor: 6.939

Review 4.  Current treatment options for colon cancer peritoneal carcinomatosis.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 5.  Metastatic colon carcinoma found within an inguinal hernia sac: report of a case.

Authors:  G Matsumoto; H Ise; H Inoue; H Ogawa; N Suzuki; S Matsuno
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Primary malignant peritoneal mesothelioma in an incarcerated groin hernia: report of a case.

Authors:  Mario Testini; Anna Scattone; Beatrice Di Venere; Germana Lissidini; Giuseppe Piccinni; Silvia Palmisano; Gabriella Serio
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

Authors:  Jan Franko; Zuhaib Ibrahim; Niraj J Gusani; Matthew P Holtzman; David L Bartlett; Herbert J Zeh
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

8.  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Sjoerd Bruin; Henk Boot; Gooike van Slooten; Harm van Tinteren
Journal:  Ann Surg Oncol       Date:  2008-06-03       Impact factor: 5.344

9.  Treatment of perforated colon carcinomas-outcomes of radical surgery.

Authors:  M Daniels; S Merkel; A Agaimy; W Hohenberger
Journal:  Int J Colorectal Dis       Date:  2015-08-07       Impact factor: 2.571

10.  Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

Authors:  Dominique Elias; François Gilly; Florent Boutitie; François Quenet; Jean-Marc Bereder; Baudouin Mansvelt; Gérard Lorimier; Pierre Dubè; Olivier Glehen
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.